Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04681742 · ClinicalTrials.gov registry record · NA
Feasibility Testing of Cognitive Strategy Training in Post-Concussive Syndrome
A NA study of Brain Concussion and Post-Concussion Syndrome, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT04681742: Completed NA study of Brain Concussion and Post-Concussion Syndrome, sponsored by University of Missouri-Columbia.
NCT04681742 is a NA study of Brain Concussion and Post-Concussion Syndrome that has completed, run by University of Missouri-Columbia. The registered enrollment target is 15 participants, below the 297-participant average among 17 other Brain Concussion trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04681742, a NA study of Brain Concussion and Post-Concussion Syndrome, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the practicality (i.e. acceptability to stakeholders; outcome battery feasibility; recruitment, retention, and adherence rates) and the preliminary effect of a cognitive strategy training intervention in adults with post-concussive syndrome.
Primary Outcome
Self-report, 8 item measures of intervention acceptability
Conditions Studied
Interventions
- BEHAVIORAL CO-OP Group
Study Locations (1)
Missouri
- University of Missouri-Columbia - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-10-15 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT04681742 record still lists
NCT04681742 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 297-participant average among 17 other Brain Concussion trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Brain Concussion appearing as the primary indexed condition, and to 1 intervention - of which CO-OP Group is the first listed.
NCT04681742 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04681742 about?
NCT04681742 is a clinical study titled "Feasibility Testing of Cognitive Strategy Training in Post-Concussive Syndrome". This study will evaluate the practicality (i.e. acceptability to stakeholders; outcome battery feasibility; recruitment, retention, and adherence rates) and the preliminary effect of a cognitive strategy training intervention in adults with post-concussive syndrome.
What is the current status of trial NCT04681742?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2020-10-15. Estimated completion is 2022-12-31.
What conditions does trial NCT04681742 study?
This clinical trial studies the following conditions: Brain Concussion, Post-Concussion Syndrome.
What interventions are being tested in trial NCT04681742?
The interventions under investigation include: CO-OP Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT04681742?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04681742 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Concussion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04681742's enrollment target sits among peer trials
15 17th of 17 higher than 1 of 17 other Brain Concussion trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Concussion trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concussion Recovery and Support Program
RECRUITING · NA
-
Exercise Reset for Concussion in a Military Environment
RECRUITING · NA
-
Problem-Solving Training for Concussion
RECRUITING · NA
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
-
Cervical Spine Focused Treatment for Patients With Persistent Concussion Symptoms and Neck Pain
RECRUITING · NA
-
Neuromodulation and Neuroimaging in Older Children With Mild Traumatic Brain Injury
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI